(Q45750997)

15 December 2017

title

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

5

Liaw YF

0 references

author name string

Lin SM

1

1 reference

15 December 2017

Sheen IS

2

1 reference

15 December 2017

Chien RN

3

1 reference

15 December 2017

Chu CM

4

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

29

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

971-975

1 reference

15 December 2017

A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Current therapeutic trends in therapy for chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Epidemiological characteristics and risk factors of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290312

7 January 2021

Identifiers

DOI

10.1002/HEP.510290312

1 reference

15 December 2017

1 reference

15 December 2017